Literature DB >> 32104577

Use of Statins in Patients With and Without Liver Disease.

Prashanth Francis1, Lisa Forman1.   

Abstract

Entities:  

Year:  2020        PMID： 32104577      PMCID： PMC7041958          DOI： 10.1002/cld.866

Source DB:  PubMed          Journal:  Clin Liver Dis (Hoboken)        ISSN： 2046-2484


× No keyword cloud information.
  38 in total

1.  Rosuvastatin-associated hepatitis with autoimmune features.

Authors:  L M M Wolters; H R Van Buuren
Journal:  Eur J Gastroenterol Hepatol       Date:  2005-05       Impact factor: 2.566

2.  Statins Reduce the Risk of Cirrhosis and Its Decompensation in Chronic Hepatitis B Patients: A Nationwide Cohort Study.

Authors:  Yi-Wen Huang; Chia-Long Lee; Sien-Sing Yang; Szu-Chieh Fu; Yun-Yi Chen; Ting-Chuan Wang; Jui-Ting Hu; Ding-Shinn Chen
Journal:  Am J Gastroenterol       Date:  2016-05-10       Impact factor: 10.864

Review 3.  Management of dyslipidemia in adult solid organ transplant recipients.

Authors:  Bruce A Warden; P Barton Duell
Journal:  J Clin Lipidol       Date:  2019-01-30       Impact factor: 4.766

4.  Statins Are Associated With a Decreased Risk of Decompensation and Death in Veterans With Hepatitis C-Related Compensated Cirrhosis.

Authors:  Arpan Mohanty; Janet P Tate; Guadalupe Garcia-Tsao
Journal:  Gastroenterology       Date:  2015-10-17       Impact factor: 22.682

Review 5.  Statin therapy in patients with cirrhosis.

Authors:  Andrew P Wright; Srinath Adusumalli; Kathleen E Corey
Journal:  Frontline Gastroenterol       Date:  2014-08-08

6.  Statin use is associated with a reduced risk of fibrosis progression in chronic hepatitis C.

Authors:  Tracey G Simon; Lindsay Y King; Hui Zheng; Raymond T Chung
Journal:  J Hepatol       Date:  2014-08-15       Impact factor: 25.083

7.  Drug-induced acute liver failure: results of a U.S. multicenter, prospective study.

Authors:  Adrian Reuben; David G Koch; William M Lee
Journal:  Hepatology       Date:  2010-10-14       Impact factor: 17.425

8.  An assessment of statin safety by hepatologists.

Authors:  David E Cohen; Frank A Anania; Naga Chalasani
Journal:  Am J Cardiol       Date:  2006-02-03       Impact factor: 2.778

9.  Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

Authors: 
Journal:  Lancet       Date:  1994-11-19       Impact factor: 79.321

10.  Reduced risk of decompensation and death associated with use of statins in patients with alcoholic cirrhosis. A nationwide case-cohort study.

Authors:  U C Bang; T Benfield; F Bendtsen
Journal:  Aliment Pharmacol Ther       Date:  2017-10       Impact factor: 8.171
View more
  2 in total

Review 1.  Statins Show Promise Against Progression of Liver Disease.

Authors:  Prashanth Francis; Lisa M Forman
Journal:  Clin Liver Dis (Hoboken)       Date:  2021-12-20

2.  Protective Effects of Statin Therapy in Cirrhosis Are Limited by a Common SLCO1B1 Transporter Variant.

Authors:  Melissa Merkel; Christina Schneider; Robin Greinert; Alexander Zipprich; Cristina Ripoll; Frank Lammert; Matthias C Reichert
Journal:  Hepatol Commun       Date:  2021-08-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.